| REVIEW ARTICLE |
|
| Year : 2023 | Volume
: 17
| Issue : 1 | Page : 108-116 |
|
|
New horizons for reduction of blood use: Patient blood management
Karim Shamsasenjan1, Somayeh Gharehdaghi2, Elham Khalaf-Adeli3, Ali Akbar Pourfathollah4
1 Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 Department of Immunology, Division of Hematology, Faculty of Medicine, Tabriz University of Medical Sciences, Tehran, Iran
3 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
4 Department of Immunology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran
Correspondence Address:
Karim Shamsasenjan
Department of Immunology, Division of Hematology, Faculty of Medicine, Tabriz University of Medical Sciences, Tehran
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ajts.ajts_14_21
|
|
|
A countrywide study over the eras indicates overuse of blood transfusion can have considerable risks to patients accompanied by significant costs of blood transfusion for patients, hospitals, and health-care systems. Besides, more than 30% of the world's population is anemic. Typically, blood transfusion helps continue suitable oxygen transfer in anemia, i.e., more and more documented as a threatening factor with several adverse outcomes including long hospitalization, morbidity, and mortality. Transplantation of allogeneic blood is thus like a two-edged sword. There is no doubt that the blood transfusion is a life-saving treatment, but it should be underpinned by much of up-to-date health-care services. The new theory considered for patient blood management (PBM) also discusses the timely application of evidence-based surgical and clinical theories and focuses on patient outcomes. Furthermore, PBM involves a multidisciplinary methodology to reduce unnecessary transfusions, minimize costs, and cut risks.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
